Abstract:Background Parkinson's disease (PD) is a prevailing neurodegenerative disorder increasingly affecting the elderly population. The involvement of microRNAs (miRNAs) in PD has been confirmed. We sought to explore the molecular mechanism of miR‐20a‐5p in PD. Methods Lipopolysaccharide (LPS)‐induced BV2 cell model and 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine hydrochloride (MPTP‐HCl)‐induced PD mouse model were established. miR‐20a‐5p, inducible nitric oxide synthase (iNOS), interleukin (IL)‐6, tumour necrosis factor (TNF)‐α, transforming growth factor (TGF)‐β1, and IL‐10 expression in BV2 cells was examined by reverse transcription – quantitative polymerase chain reaction. Cell viability was assessed by MTT assay. The apoptotic rate and levels of Bcl‐2, Bax, cleaved caspase‐3, and signal transducer and activator of transmission (STAT)3 were examined by flow cytometry and Western blot. Bioinformatics software predicted the potential binding sites of miR‐20a‐5p and STAT3. Dual‐luciferase experiment verified the binding relationship. Iba1‐positive and tyrosine hydroxylase (TH)‐positive cell numbers in substantia nigra pars compacta were detected by immunohistochemistry. The effect of miR‐20a‐5p on motor function in MPTP‐induced PD mice was detected by Rota‐rod test, Pole test, Traction test and Beam‐crossing task. Results miR‐20a‐5p was under‐expressed in LPS‐induced BV2 cells. Overexpression of miR‐20a‐5p increased the viability of LPS‐induced BV2 cells and reduced apoptosis rates. Moreover, overexpression of miR‐20a‐5p reduced cleaved caspase‐3, Bax, iNOS, IL‐6, and TNF‐α and increased Bcl‐2 and TGF‐β1, and IL‐10. miR‐20a‐5p targeted STAT3. STAT3 overexpression partially reversed miR‐20a‐5p overexpression‐mediated effects on LPS‐induced BV2 cell viability, apoptosis, and inflammatory responses. miR‐20a‐5p overexpression inhibited MPTP‐induced STAT3 and α‐synuclein levels, microglia activation, and inflammatory response, and reduced the loss of TH‐positive cells in mice. miR‐20a‐5p overexpression ameliorated MPTP‐induced dyskinesia in PD model mice. Conclusion miR‐20a‐5p alleviates neuronal damage and suppresses inflammation by targeting STAT3 in PD.

miR-101a-3p/ROCK2 axis regulates neuronal injury in Parkinson's disease models

Rho kinase II interference by small hairpin RNA ameliorates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice

MiR-410 exerts neuroprotective effects in a cellular model of Parkinson's disease induced by 6-hydroxydopamine via inhibiting the PTEN/AKT/mTOR signaling pathway

Neuroprotective effect of microRNA-99a against focal cerebral ischemia–reperfusion injury in mice

Suppression Of Microrna-342-3p Increases Glutamate Transporters And Prevents Dopaminergic Neuron Loss Through Activating The Wnt Signaling Pathway Via P21-Activated Kinase 1 In Mice With Parkinson'S Disease

ROCK1 induces dopaminergic nerve cell apoptosis via the activation of Drp1-mediated aberrant mitochondrial fission in Parkinson’s disease

MicroRNA‐190 alleviates neuronal damage and inhibits neuroinflammation via Nlrp3 in MPTP‐induced Parkinson's disease mouse model

Regulation of TIR-1/SARM-1 by miR-71 Protects Dopaminergic Neurons in a C. elegans Model of LRRK2-Induced Parkinson's Disease

miR-103a-3p regulates mitophagy in Parkinson’s disease through Parkin/Ambra1 signaling

Retracted: Suppression of Microrna‐342‐3p Increases Glutamate Transporters and Prevents Dopaminergic Neuron Loss Through Activating the Wnt Signaling Pathway Via P21‐activated Kinase 1 in Mice with Parkinson's Disease

miR-214-3p promotes the pathogenesis of Parkinson's disease by inhibiting autophagy

Regulation of miR-590-5p on Neurological Inflammation and Oxidative Stress and Its Biomarker Role in Parkinson's Disease

MicroRNA-218-5p-Ddx41 axis restrains microglia-mediated neuroinflammation through downregulating type I interferon response in a mouse model of Parkinson’s disease

MicroRNA-212-5p Prevents Dopaminergic Neuron Death by Inhibiting SIRT2 in MPTP-Induced Mouse Model of Parkinson’s Disease

Regulatory mechanism of miR‐20a‐5p in neuronal damage and inflammation in lipopolysaccharide‐induced BV2 cells and MPTP‐HCl‐induced Parkinson's disease mice

Targeting the RUNX3-miR-186-3p-DAT-IGF1R axis as a therapeutic strategy in a Parkinson's disease model

Long non-coding RNA myocardial infarction-associated transcript promotes 1-Methyl-4-phenylpyridinium ion-induced neuronal inflammation and oxidative stress in Parkinson's disease through regulating microRNA-221-3p/ transforming growth factor /nuclear factor E2-related factor 2 axis

Regulation of Mir-590-5p on Neurological Inflammation and Oxidative Stress and Its Biomarker Role in Parkinson’s Disease

Circular RNA hsa_circ_0004381 Promotes Neuronal Injury in Parkinson's Disease Cell Model by miR-185-5p/RAC1 Axis

Mir-141-3p Regulates Apoptosis and Mitochondrial Membrane Potential Via Targeting Sirtuin1 in a 1-Methyl-4-phenylpyridinium in Vitro Model of Parkinson's Disease.

Silencing of Mir-497-5p Inhibits Cell Apoptosis and Promotes Autophagy in Parkinson's Disease by Upregulation of FGF2